F.D.A. Advisers Say Benefits of Over-the-Counter Birth Control Pill Outweigh Risks
The agency is expected to decide this summer whether to allow the first nonprescription sales of an oral contraceptive in the United States.
Call for more information
888-531-0245
info@siii-clinical.com
From research laboratories to clinical settings, SIII integrates the technologies, resources, and expertise our customers need to rise to the next opportunity. SIII is dedicated to exploring and researching the processes and scientific mechanisms underlying the world we live in.